1,513
Views
24
CrossRef citations to date
0
Altmetric
RESEARCH PAPERS

Interplay between VEGF-A and cMET signaling in human vestibular schwannomas and schwann cells

, &
Pages 170-175 | Received 10 Jul 2014, Accepted 28 Sep 2014, Published online: 18 Feb 2015

References

  • Mahaley MSJ, Mettlin C, Natarajan N, Laws ERJ, Peace BB, Analysis of patterns of care of brain tumor patients in the United States: A study of the brain tumor section of the AANS and the CNS and the commission on cancer of the ACS. Clin Neurosurg 1990; 36:347-5; PMID:2295209
  • Caye-Thomasen P, Werther K, Nalla A, Bøg-Hansen TC, Nielsen HJ, Stangerup SE, Thomsen J, VEGF and VEGF receptor-1 concentration in vestibular schwannoma homogenates correlates to tumor growth rate. Otol Neurotol 2005; 26(1):98-101; PMID:15699727
  • Plotkin SR, Stemmer-Rachamimov A, Barker FG, Halpin C, Padera TP, Tyrrell A, Sorensen AG, Jain RK, di Tomaso E, Hearing improvement after bevacizumab in patients with neurofibromatosis type 2. N Engl J Med 2009; 361(4):358-367; PMID:19587327; http://dx.doi.org/10.1056/NEJMoa0902579
  • Plotkin SR, Merker VL, Halpin C, Jennings D, McKenna MJ, Harris GJ, Barker FG 2nd. Bevacizumab for progressive vestibular schwannoma in neurofibromatosis type 2: A retrospective review of 31 patients. Otol Neurotol 2012; 33(6):1046-52; PMID:22805104; http://dx.doi.org/10.1097/MAO.0b013e31825e73f5
  • Gherardi E, Birchmeier W, Birchmeier C, Woude GV. Targeting MET in cancer: Rationale and progress. Nat Rev Cancer 2012; 12(2):89-103; PMID:22270953; http://dx.doi.org/10.1038/nrc3205
  • Moriyama T, Kataoka H, Kawano H, Yokogami K, Nakano S, Goya T, Uchino H, Koono M, Wakisaka S. Comparative analysis of expression of hepatocyte growth factor and its receptor, c-met, in gliomas, meningiomas and schwannomas in humans. Cancer Lett 1998; 124(2):149-155; PMID:9500204; http://dx.doi.org/10.1016/S0304-3835(97)00469-2
  • Sulpice E, Ding S, Muscatelli-Groux B, Bergé M, Han ZC, Plouet J, Tobelem G, Merkulova-Rainon T. Cross-talk between the VEGF-A and HGF signalling pathways in endothelial cells. Biol Cell 2009; 101(9):525-539; PMID:19281453; http://dx.doi.org/10.1042/BC20080221
  • Matsumura A, Kubota T, Taiyoh H, Fujiwara H, Okamoto K, Ichikawa D, Shiozaki A, Komatsu S, Nakanishi M, Kuriu Y, et al. HGF regulates VEGF expression via the c-met receptor downstream pathways, PI3K/Akt, MAPK and STAT3, in CT26 murine cells. Int J Oncol 2013; 42(2):535-542; PMID:23233163; http://dx.doi.org/10.3892/ijo.2012.1728
  • Moriyama T, Kataoka H, Hamasuna R, Yokogami K, Uehara H, Kawano H, Goya T, Tsubouchi H, Koono M, Wakisaka S. Up-regulation of vascular endothelial growth factor induced by hepatocyte growth Factor/Scatter factor stimulation in human glioma cells. Biochem Biophys Res Commun 1998; 249(1):73-77; PMID:9705834; http://dx.doi.org/10.1006/bbrc.1998.9078
  • Wong HK, Lahdenranta J, Kamoun WS, Chan AW, McClatchey AI, Plotkin SR, Jain RK, di Tomaso E, Anti-Vascular endothelial growth factor therapies as a novel therapeutic approach to treating neurofibromatosis-related tumors. Cancer Res 2010; 70(9):3483-3493; PMID:20406973; http://dx.doi.org/10.1158/0008-5472.CAN-09-3107
  • Tokuda H, Takai S, Hanai Y, Harada A, Matsushima-Nishiwaki R, Kato H, Ogura S, Kozawa O. Potentiation by platelet-derived growth factor-BB of FGF-2-stimulated VEGF release in osteoblasts. J Bone Miner Metab 2008; 26(4):335-341; PMID:18600399; http://dx.doi.org/10.1007/s00774-007-0829-x
  • Lieu CH, Tran H, Jiang Z, Mao M, Overman MJ, Lin E, Eng C, Morris J, Ellis L, Heymach JV, et al. The association of alternate VEGF ligands with resistance to anti-VEGF therapy in metastatic colorectal cancer. PLoS ONE 2013; 8(10):e77117; PMID:24143206; http://dx.doi.org/10.1371/journal.pone.0077117
  • McCarty JH. Glioblastoma resistance to anti-VEGF therapy: has the challenge been MET? Clin Cancer Res 2013; 19(7):1631-1633; PMID:23403631; http://dx.doi.org/10.1158/1078-0432.CCR-13-0051
  • Dilwali S, Lysaght A, Roberts D, Barker FG,II, McKenna MJ, Stankovic KM. Sporadic vestibular schwannomas associated with good hearing secrete higher levels of fibroblast growth factor 2 than those associated with poor hearing irrespective of tumor size. Otol Neurotol 2013; 34(4):748-754; PMID:23512073; http://dx.doi.org/10.1097/MAO.0b013e31828048ec
  • Dilwali S, Patel PB, Roberts DS, Basinsky GM, Harris GJ, Emerick KS, Stankovic KM. Primary culture of human schwann and schwannoma cells: Improved and simplified protocol. Hear Res 2014; 315:25-33; PMID:24910344; http://dx.doi.org/10.1016/j.heares.2014.05.006

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.